Did you know that injectable dermal fillers are the second most popular minimally-invasive cosmetic procedure in the U.S.? According to annual statistics put together by the American Society of Plastic Surgeons, more than 3 million dermal injection filler treatments were performed in 2020.
When you consider options for reducing the appearance of wrinkles, fine lines, and crow’s feet, Botox® is likely one of the first minimally invasive remedies to come to mind. That’s because Botox® was the first neuromodulator to be approved by the FDA for cosmetic purposes, making it the go-to injectable anti-wrinkle treatment since 1989.
Botox® is a brand name which has become well-known for its ability to reduce the appearance of wrinkles, facial lines and other signs of aging. Many people may not be aware of Botox® alternatives that may offer similar, if not better, age-defying results in treating moderate to severe wrinkles. In particular, FDA-approved Xeomin® has been making its mark in recent years as an effective go-to alternative to Botox®. While Xeomin’s® rising popularity was driven in large by demand from those who became immune to Botox®, the injectable’s effectiveness has made it a viable alternative in its own right.